Authors: R. Kožnarová Authors‘ workplace: Ředitel: MUDr. Štefan Vítko, CSc. ; Institut klinické a experimentální medicíny, Praha ; Přednosta: Doc. MUDr. František SAUDEK, DrSc. ; Klinika diabetologie ; Přednosta: prof. MUDr. Terezie Pelikánová, DrSc. ; Centrum diabetologie Published in: Prakt. Lék. 2007; 87(2): 73-76 Category: Reviews
Diabetes control through subcutaneous insulin infusion (CSII) is currently the therapeutic option that most closely mimics physiologic insulin secretion and provides for glycemia levels close to normal even where standard injection insulin therapy fails. Following CSII installation, the mean daily dose of insulin usually decreases and diabetes control improves (HBA1c falls). Most patients have the CSII installed because of poor diabetes control. The most frequent indications are the “dawn phenomenon”, severe hypoglycemia, and progression of diabetic complications.
Key words: Diabetes mellitus, continuous subcutaneous insulin infusion (CSII), insulin pump.
Don‘t have an account? Create new account
Enter the email address that you registered with. We will send you instructions on how to set a new password.
